Author:
Monahan Paul E.,Abajas Yasmina L.
Publisher
Springer International Publishing
Reference74 articles.
1. Anguela XM, Sharma R, Doyon Y, Miller JC, Li H, Haurigot V, et al. Robust ZFN-mediated genome editing in adult hemophilic mice. Blood. 2013;122(19):3283–7.
2. Annoni A, Brown BD, Cantore A, Sergi Sergi L, Naldini L, Roncarolo M-G. In vivo delivery of a microRNA-regulated transgene induces antigen-specific regulatory T cells and promotes immunological tolerance. Blood. 2009;114(25):5152–61.
3. Annoni A, Cantore A, Della Valle P, Goudy K, Akbarpour M, Russo F, et al. Liver gene therapy by lentiviral vectors reverses anti-factor IX pre-existing immunity in haemophilic mice. EMBO Mol Med. 2013;5(11):1684–97.
4. Arruda VR, Hagstrom JN, Deitch J, Heiman-Patterson T, Camire RM, Chu K, et al. Posttranslational modifications of recombinant myotube-synthesized human factor IX. Blood. 2001;97(1):130–8.
5. Barzel A, Paulk N, Shi Y, Huang Y, Chu K, Zhang F, et al. Promoterless gene targeting without nucleases ameliorates haemophilia B in mice. Nat Nat Publ Group. 2015;517(7534):360–4.